DIS-CHEM PHARMACIES LIMITED - Dealings in securities

Dealings in securities

Dis-Chem Pharmacies Limited
(Incorporated in the Republic of South Africa)
(Registration number 2005/009766/06)
JSE share code: DCP
ISIN: ZAE000227831
(“Dis-Chem” or the “Company”)

ANNOUNCEMENT REGARDING:
   • DEALINGS IN DIS-CHEM SHARES BY AN ASSOCIATE OF A PRESCRIBED OFFICER OF THE COMPANY; AND
   • NOTIFICATION IN TERMS OF SECTION 122(3)(b) OF THE COMPANIES ACT (ACT 71 OF 2008), PARAGRAPH
      3.83(b) and PARAGRAPH 3.63 TO 3.74 OF THE JSE LIMITED LISTINGS REQUIREMENTS; AND

Dealings in securities

In compliance with sections 3.63 to 3.74 of the Listings Requirements of the JSE Limited, the following information is
disclosed:

Name of prescribed officer:                 Mr Stanley Goetsch
Name of associate:                          Stansch Proprietary Limited (“Stansch”), a company owned by the
                                            prescribed officer’s family trust
Nature and extent of interest:              Indirect beneficial

Class of securities:                        Ordinary shares
Number of shares:                           1 580 000
Price per security:                         R36.95
Total value of transaction:                 R 58 381 000.00
Date of transaction:                        20 January 2022

Class of securities:                        Ordinary shares
Number of shares:                           1 000 000
Price per security:                         R36.9147
Total value of transaction:                 R 36 914 700.00
Date of transaction:                        20 January 2022

Class of securities:                        Ordinary shares
Number of shares:                           2 420 000
Price per security:                         R36.50
Total value of transaction:                 R 88 330 000
Date of transaction:                        21 January 2022

Nature of transactions:                     On-market disposal of Dis-Chem ordinary shares

Clearance for the above transactions were obtained in accordance with Dis-Chem’s trading policy.

Change in beneficial ownership

Shareholders are advised that further to the details set out above, the Company has received formal notification in
the prescribed form that Stansch disposed of an interest in the ordinary share capital of Dis-Chem, such that the total
interest in the ordinary share capital of the Company held by Stansch now amounts to 4.64% of the total issued
ordinary share capital of Dis-Chem.

The Company has notified the Takeover Regulation Panel of the above in accordance with its obligations under section
122 of the Companies Act.

By order of the Board
Nikki Lumley
Company Secretary

25 January 2022

Sponsor
The Standard Bank of South Africa Limited

Date: 25-01-2022 08:35:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.